BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1693451)

  • 1. Is the imbalance between thrombin and plasmin activity in diabetes related to the behaviour of antiplasmin activity?
    Marongiu F; Conti M; Mameli G; Sorano GG; Cossu E; Cirillo R; Balestrieri A
    Thromb Res; 1990 Apr; 58(2):91-9. PubMed ID: 1693451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of blood coagulation and fibrinolysis in psoriasis.
    Marongiu F; Sorano GG; Bibbò C; Pistis MP; Conti M; Mulas P; Balestrieri A; Biggio P
    Dermatology; 1994; 189(1):32-7. PubMed ID: 7516205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of thrombosis and fibrinolysis following brain infarction.
    Kataoka S; Hirose G; Hori A; Shirakawa T; Saigan T
    J Neurol Sci; 2000 Dec; 181(1-2):82-8. PubMed ID: 11099716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of exercise on thrombin and plasmin generation in middle-aged men.
    Small M; Simpson I; McGhie I; Douglas JT; Lowe GD; Forbes CD
    Haemostasis; 1987; 17(6):371-6. PubMed ID: 2962911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Wound healing, blood coagulation and fibrinolysis during operations involving gastric cancer surgery].
    Gando S; Kamiya K; Makise H; Tedo I; Nakanishi Y
    Nihon Geka Gakkai Zasshi; 1989 Jan; 90(1):59-63. PubMed ID: 2565016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinopeptide A and B beta 15-42 in liver cirrhosis.
    Marongiu F; Mameli G; Acca MR; Mulas G; Medda A; Tronci MB; Mamusa AM; Balestrieri A
    Haemostasis; 1988; 18(2):126-8. PubMed ID: 2457543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of blood coagulation and fibrinolysis in diabetes mellitus: evaluation by plasma levels of thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex.
    Takahashi H; Tsuda A; Tatewaki W; Wada K; Niwano H; Shibata A
    Thromb Res; 1989 Sep; 55(6):727-35. PubMed ID: 2528845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activity of the coagulation and fibrinolysis in non-insulin-dependent diabetes mellitus. In vivo study].
    Conti M; Marongiu F; Mameli G; Mamusa AM; Cambuli AB; Cossu E; Sorano GG; Biondi G; Cirillo R; Balestrieri A
    Recenti Prog Med; 1989 Jun; 80(6):297-9. PubMed ID: 2772395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The polymerization and thrombin-binding properties of des-(B beta 1-42)-fibrin.
    Siebenlist KR; DiOrio JP; Budzynski AZ; Mosesson MW
    J Biol Chem; 1990 Oct; 265(30):18650-5. PubMed ID: 2211727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin and plasmin activity in diabetes mellitus and their association with glycaemic control.
    Small M; Lowe GD; MacCuish AC; Forbes CD
    Q J Med; 1987 Dec; 65(248):1025-31. PubMed ID: 2971234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markers.
    Kambayashi J; Sakon M; Yokota M; Shiba E; Kawasaki T; Mori T
    Thromb Res; 1990 Oct; 60(2):157-67. PubMed ID: 2149215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin and plasmin activity in coronary artery disease.
    Small M; Lowe GD; Douglas JT; Hutton I; Lorimer AR; Forbes CD
    Br Heart J; 1988 Sep; 60(3):201-3. PubMed ID: 2972304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of labor on thrombotic and fibrinolytic systems.
    Yoshimura T; Ito M; Nakamura T; Okamura H
    Eur J Obstet Gynecol Reprod Biol; 1992 May; 44(3):195-9. PubMed ID: 1535054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased fibrin/fibrinogen degradation products without increase of plasmin-alpha 2-plasmin inhibitor complex after hepatectomy for hepatocellular carcinoma.
    Takeda S; Katoh H; Takaki A; Okamoto K; Ohsato K
    Thromb Res; 1990 Jan; 57(2):289-300. PubMed ID: 2156347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation and fibrinolysis activation markers in prostatic carcinoma patients.
    Geenen RW; Delaere KP; van Wersch JW
    Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):69-72. PubMed ID: 9056745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian variations of plasma levels of blood coagulation/fibrinolysis molecular markers in progressive systemic sclerosis (PSS).
    Maeda M; Kachi H; Kitajima Y
    J Dermatol Sci; 1996 Oct; 13(1):18-24. PubMed ID: 8902649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
    Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The coagulation system is activated in idiopathic cardiomyopathy.
    Yamamoto K; Ikeda U; Furuhashi K; Irokawa M; Nakayama T; Shimada K
    J Am Coll Cardiol; 1995 Jun; 25(7):1634-40. PubMed ID: 7539015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of haemostatic markers in various subtypes and phases of stroke.
    Yamazaki M; Uchiyama S; Maruyama S
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):707-12. PubMed ID: 7507362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.